Necroptosis

Necroptosis is a regulated form of programmed cell death that shares morphological characteristics with necrosis but is mechanistically distinct from apoptosis. Unlike apoptosis, which is caspase-dependent and generally non-inflammatory, necroptosis is caspase-independent and typically results in the rupture of the plasma membrane, leading to the release of intracellular contents that can provoke an inflammatory response. Necroptosis serves as an alternative cell death pathway activated under certain pathological or physiological conditions, particularly when apoptosis is inhibited.

Molecular Mechanisms of Necroptosis

Necroptosis is initiated by specific extracellular and intracellular signals that engage death receptors, pattern recognition receptors, or other stress sensors. The core molecular machinery involves receptor-interacting protein kinases 1 and 3 (RIPK1 and RIPK3), and the mixed lineage kinase domain-like protein (MLKL).

Necroptotic Initiation

Necroptosis commonly begins when death receptors such as tumor necrosis factor receptor 1 (TNFR1) are activated by their ligands (e.g., TNF-α). Under normal conditions, TNFR1 activation leads to survival or apoptosis depending on cellular context. However, when caspase-8 is inhibited or absent, the apoptotic pathway is blocked, allowing necroptosis to proceed. This shift in cell death modality is critical in immune responses and pathological settings.

Upon TNFR1 ligation, RIPK1 is recruited to the receptor complex. If apoptosis is inhibited, RIPK1 interacts with RIPK3 through their RIP homotypic interaction motifs (RHIM) domains to form a multiprotein signaling complex known as the necrosome. The necrosome acts as a platform for downstream signaling events.

RIPK1 and RIPK3 Signaling

RIPK1 and RIPK3 are serine/threonine kinases that propagate necroptotic signaling. RIPK1 acts as a molecular switch, determining cell fate between survival, apoptosis, and necroptosis based on post-translational modifications such as ubiquitination and phosphorylation.

In necroptosis, RIPK1 binds and phosphorylates RIPK3, which in turn undergoes autophosphorylation, amplifying the necroptotic signal. This kinase activity is essential for recruiting and phosphorylating MLKL. The interaction between RIPK1 and RIPK3 is stabilized by RHIM-RHIM domain interactions, which are vital for necrosome formation.

In addition to TNFR1, other receptors and sensors like Toll-like receptors (TLR3 and TLR4) and Z-DNA binding protein 1 (ZBP1) can trigger RIPK3-dependent necroptosis through similar molecular mechanisms.

MLKL Activation and Membrane Targeting

MLKL is the executioner protein in necroptosis. After phosphorylation by RIPK3, MLKL undergoes a conformational change that exposes its N-terminal four-helix bundle domain, enabling it to translocate to cellular membranes.

Once activated, MLKL oligomerizes and inserts into the plasma membrane or intracellular organelle membranes, disrupting membrane integrity. This targeting is essential for the final steps of necroptotic cell death.

MLKL-mediated membrane disruption involves the formation of pores or channels that compromise ion homeostasis, leading to cell swelling, loss of membrane potential, and eventual rupture.

Necroptotic Membrane Rupture and Cellular Consequences

The hallmark of necroptosis is the rupture of the plasma membrane, which contrasts with the membrane blebbing and fragmentation observed in apoptosis. MLKL oligomers disrupt the lipid bilayer, causing an influx of ions and water, resulting in cell swelling (oncosis) and membrane rupture.

This rupture releases intracellular components such as damage-associated molecular patterns (DAMPs), including HMGB1, ATP, and nucleic acids, into the extracellular space. These molecules act as pro-inflammatory signals, recruiting and activating immune cells.

Necroptosis plays significant roles in host defense, inflammation, and disease pathogenesis. It can limit the spread of certain pathogens by inducing inflammatory cell death but may also contribute to tissue damage in conditions such as ischemia-reperfusion injury, neurodegeneration, and chronic inflammatory diseases.

Regulation of Necroptosis

Necroptosis is tightly regulated to prevent unwarranted cell death and inflammation. Key regulatory mechanisms include:

• Caspase-8 activity: Caspase-8 cleaves RIPK1 and RIPK3, inhibiting necroptosis and favoring apoptosis.
• Ubiquitination: Post-translational modifications of RIPK1 influence its interactions and downstream signaling.
• Cellular inhibitors: Proteins like cellular FLICE-like inhibitory protein (cFLIP) modulate the balance between apoptosis and necroptosis.
• Phosphatases and chaperones: These can modulate the phosphorylation status and stability of necroptotic proteins.

Defects or dysregulation in these controls can lead to excessive necroptosis, contributing to pathological inflammation and tissue injury.

Physiological and Pathological Roles

Necroptosis contributes to multiple physiological and pathological processes:

• Host defense: Necroptosis acts as a backup mechanism to eliminate infected or damaged cells when apoptosis is inhibited by pathogens.
• Inflammation: The release of DAMPs during necroptosis promotes immune activation and inflammatory responses.
• Tissue injury: Excessive or chronic necroptosis contributes to diseases such as inflammatory bowel disease, neurodegeneration, myocardial infarction, and acute kidney injury.
• Cancer: Necroptosis can have dual roles, either suppressing tumor growth by killing cancer cells or promoting tumor progression via inflammation.

Understanding necroptosis provides insights into novel therapeutic targets for controlling inflammation and cell death in various diseases.